Search

Displaying results 8801 - 8810 of 8970 in total
  1. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

  2. Drug

    AMGN-0007

    go.drugbank.com/drugs/DB06511
    Experimental

    Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.

  3. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental

  4. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  5. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  6. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  7. Drug

    Amediplase

    go.drugbank.com/drugs/DB06679
    Experimental

    Amediplase is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain from the A-chain of tissue plasminogen activator (t-PA) and the carboxy terminal region of pro-urokinase.

  8. Drug

    MBX-2044

    go.drugbank.com/drugs/DB05598
    Investigational

    MBX-2044 was under investigation in clinical trial NCT00422487 (Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes).

  9. Drug

    Tonabersat

    go.drugbank.com/drugs/DB06578
    Investigational

  10. Drug

    FG-2216

    go.drugbank.com/drugs/DB08687
    Investigational

    A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.